Hemab Therapeutics Holdings, Inc. (COAG) Insider Trading

Name: Hemab Therapeutics Holdings, Inc. (COAG) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 25, 2026): Walbert Keli (Director): Grant/Award of 36,000 shares.

Get alerted when insiders trade COAG

Email address

Loading company data...

Beta

Loading company details...

Beta